## **Core Concept**
Sipple syndrome, also known as **Multiple Endocrine Neoplasia Type 2A (MEN2A)**, is a rare hereditary disorder characterized by the occurrence of tumors in multiple endocrine glands. It primarily affects the **thyroid**, **parathyroid**, and **adrenal glands**. This syndrome is associated with mutations in the **RET proto-oncogene**.

## **Why the Correct Answer is Right**
The correct answer, which is not explicitly provided, relates to the characteristics of Sipple syndrome or MEN2A. Typically, MEN2A is characterized by the presence of **medullary thyroid carcinoma**, **pheochromocytoma** (adrenal tumor), and **hyperparathyroidism**. The syndrome is caused by mutations in the **RET proto-oncogene**, which plays a critical role in cell signaling pathways. This mutation leads to the constitutive activation of the RET protein, promoting tumor growth.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without the specific details of option A, it's challenging to provide a direct explanation. However, any option that does not accurately describe a feature of MEN2A, such as the types of tumors associated with it or the genetic basis, would be incorrect.
- **Option B:** Similarly, if option B does not align with known characteristics of MEN2A, such as the involvement of specific endocrine glands or the genetic mutation responsible, it would be considered incorrect.
- **Option C:** This option would be incorrect if it suggests features not typical of MEN2A or omits critical aspects of the syndrome.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for MEN2A (Sipple syndrome) is that **screening for RET proto-oncogene mutations** is crucial in families with a history of the syndrome. Early identification allows for **prophylactic thyroidectomy** to prevent medullary thyroid carcinoma, which is often the first manifestation of the disease. This highlights the importance of genetic screening in managing hereditary conditions.

## **Correct Answer: D.**